These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 10642749)
1. Characterization of striatal lesions produced by glutamate uptake alteration: cell death, reactive gliosis, and changes in GLT1 and GADD45 mRNA expression. Lievens JC; Bernal F; Forni C; Mahy N; Kerkerian-Le Goff L Glia; 2000 Feb; 29(3):222-32. PubMed ID: 10642749 [TBL] [Abstract][Full Text] [Related]
2. Continuous administration of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate produces striatal lesion. Liévens JC; Dutertre M; Forni C; Salin P; Kerkerian-Le Goff L Brain Res Mol Brain Res; 1997 Oct; 50(1-2):181-9. PubMed ID: 9406933 [TBL] [Abstract][Full Text] [Related]
3. Dissociation between hippocampal neuronal loss, astroglial and microglial reactivity after pharmacologically induced reverse glutamate transport. de Yebra L; Malpesa Y; Ursu G; Pugliese M; Liévens JC; Kerkerian-Le Goff L; Mahy N Neurochem Int; 2006 Dec; 49(7):691-7. PubMed ID: 16965840 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of corticostriatal and thalamostriatal deafferentation on expression of the glutamate transporter GLT1 in the rat striatum. Liévens JC; Salin P; Had-Aissouni L; Mahy N; Kerkerian-Le Goff L J Neurochem; 2000 Mar; 74(3):909-19. PubMed ID: 10693921 [TBL] [Abstract][Full Text] [Related]
5. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. Rodrigues RW; Gomide VC; Chadi G Int J Neurosci; 2001 Jul; 109(1-2):91-126. PubMed ID: 11699344 [TBL] [Abstract][Full Text] [Related]
6. Increased levels of nerve growth factor (NGF) protein and mRNA and reactive gliosis following kainic acid injection into the rat striatum. Strauss S; Otten U; Joggerst B; Plüss K; Volk B Neurosci Lett; 1994 Feb; 168(1-2):193-6. PubMed ID: 8028775 [TBL] [Abstract][Full Text] [Related]
7. Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor. Maeda J; Higuchi M; Inaji M; Ji B; Haneda E; Okauchi T; Zhang MR; Suzuki K; Suhara T Brain Res; 2007 Jul; 1157():100-11. PubMed ID: 17540348 [TBL] [Abstract][Full Text] [Related]
8. Glutamate transport alteration triggers differentiation-state selective oxidative death of cultured astrocytes: a mechanism different from excitotoxicity depending on intracellular GSH contents. Ré DB; Boucraut J; Samuel D; Birman S; Kerkerian-Le Goff L; Had-Aissouni L J Neurochem; 2003 Jun; 85(5):1159-70. PubMed ID: 12753075 [TBL] [Abstract][Full Text] [Related]
9. Ischemia induced changes in expression of the astrocyte glutamate transporter GLT1 in hippocampus of the rat. Bruhn T; Levy LM; Nielsen M; Christensen T; Johansen FF; Diemer NH Neurochem Int; 2000; 37(2-3):277-85. PubMed ID: 10812213 [TBL] [Abstract][Full Text] [Related]
10. Short- and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes. Björklund H; Olson L; Dahl D; Schwarcz R Brain Res; 1986 Apr; 371(2):267-77. PubMed ID: 2938667 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia-ischemia causes abnormalities in glutamate transporters and death of astroglia and neurons in newborn striatum. Martin LJ; Brambrink AM; Lehmann C; Portera-Cailliau C; Koehler R; Rothstein J; Traystman RJ Ann Neurol; 1997 Sep; 42(3):335-48. PubMed ID: 9307255 [TBL] [Abstract][Full Text] [Related]
12. Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporter GLT1 at hippocampal synapses. Xu NJ; Bao L; Fan HP; Bao GB; Pu L; Lu YJ; Wu CF; Zhang X; Pei G J Neurosci; 2003 Jun; 23(11):4775-84. PubMed ID: 12805317 [TBL] [Abstract][Full Text] [Related]
13. Effect of unilateral lesion of the nigrostriatal dopamine pathway on survival and neurochemistry of parafascicular nucleus neurons in the rat--evaluation of time-course and LGR8 expression. Sedaghat K; Finkelstein DI; Gundlach AL Brain Res; 2009 May; 1271():83-94. PubMed ID: 19328193 [TBL] [Abstract][Full Text] [Related]
14. Long-term effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions. Petegnief V; Saura J; Dewar D; Cummins DJ; Dragunow M; Mahy N Neuroscience; 1999; 94(1):105-15. PubMed ID: 10613501 [TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor (bFGF) injection activates the glial reaction in the injured adult rat brain. Eclancher F; Kehrli P; Labourdette G; Sensenbrenner M Brain Res; 1996 Oct; 737(1-2):201-14. PubMed ID: 8930367 [TBL] [Abstract][Full Text] [Related]
16. Protective role of melatonin in domoic acid-induced neuronal damage in the hippocampus of adult rats. Ananth C; Gopalakrishnakone P; Kaur C Hippocampus; 2003; 13(3):375-87. PubMed ID: 12722978 [TBL] [Abstract][Full Text] [Related]
17. Nigrostriatal denervation does not affect glutamate transporter mRNA expression but subsequent levodopa treatment selectively increases GLT1 mRNA and protein expression in the rat striatum. Liévens JC; Salin P; Nieoullon A; Kerkerian-Le Goff L J Neurochem; 2001 Nov; 79(4):893-902. PubMed ID: 11723182 [TBL] [Abstract][Full Text] [Related]
18. GLT1, glial glutamate transporter, is transiently expressed in neurons and develops astrocyte specificity only after midgestation in the ovine fetal brain. Northington FJ; Traystman RJ; Koehler RC; Martin LJ J Neurobiol; 1999 Jun; 39(4):515-26. PubMed ID: 10380073 [TBL] [Abstract][Full Text] [Related]
19. Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA(A) receptor changes. Brickell KL; Nicholson LF; Waldvogel HJ; Faull RL J Chem Neuroanat; 1999 Oct; 17(2):75-97. PubMed ID: 10585160 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of the substrate inhibitor l-trans-pyrrolidine-2,4-dicarboxylate (PDC) and the non-substrate inhibitor DL-threo-beta-benzyloxyaspartate (DL-TBOA) of glutamate transporters on neuronal damage and extracellular amino acid levels in rat brain in vivo. Montiel T; Camacho A; Estrada-Sánchez AM; Massieu L Neuroscience; 2005; 133(3):667-78. PubMed ID: 15890455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]